Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Journal of Nanobiotechnology|March 22, 2025
Diselenide-based nanoparticles enhancing the radioprotection to the small intestine of miceYichi Huang, Jiaze Li, Sen Wang, et al.Oxidative Medicine and Cellular Longevity|August 18, 2018
The Protective Effect of New Compound XH-103 on Radiation-Induced GI SyndromeYinping Dong, Ying Cheng, Qinlian Hou, et al.European Journal of Pharmacology|September 29, 2023
KZ02 enhances the radiosensitivity of BRAF-mutated CRC in vitro and in vivoYuying Guo, Xuejiao Li, Renbin Yuan, et al.Journal of Cellular and Molecular Medicine|January 22, 2019
The protective effects of XH-105 against radiation-induced intestinal injuryYing Cheng, Yinping Dong, Qinlian Hou, et al.Bioorganic Chemistry|March 8, 2016
Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitorsNa Liu, Yanfen Wang, Gongchao Huang, et al.Oxidative Medicine and Cellular Longevity|September 2, 2021
Design, Synthesis, and Biological Evaluation of a Novel Aminothiol Compound as Potential RadioprotectorXuejiao Li, Xinxin Wang, Longfei Miao, et al.Journal of Cellular and Molecular Medicine|May 8, 2021
Synthesis and radioprotective effects of novel hybrid compounds containing edaravone analogue and 3-n-butylphthalide ring-opening derivativesXuejiao Li, Xinxin Wang, Longfei Miao, et al.ACS Biomaterials Science & Engineering|April 7, 2021
Oral Codelivery of WR-1065 Using Curcumin-Linked ROS-Sensitive Nanoparticles for Synergistic RadioprotectionYahong Liu, Longfei Miao, Yuying Guo, et al.Journal of Radiation Research|March 17, 2020
Protective effects of new aryl sulfone derivatives against radiation-induced hematopoietic injuryJian Cao, Hongyan Li, Renbin Yuan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2026
Efficacy and Safety of Tunlametinib in Adults with Inoperable Neurofibromatosis Type 1-Associated Plexiform Neurofibromas: Phase IIa Trial and Biomarker ResearchZhichao Wang, Jingxuan Huang, Jun Liu, et al.Pageof 4